Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Differentiation of pancreatic cysts with optical coherence tomography (OCT) imaging: an ex vivo pilot study.

Iftimia N, Cizginer S, Deshpande V, Pitman M, Tatli S, Iftimia NA, Hammer DX, Mujat M, Ustun T, Ferguson RD, Brugge WR.

Biomed Opt Express. 2011 Aug 1;2(8):2372-82. doi: 10.1364/BOE.2.002372. Epub 2011 Jul 25.

3.

Overview of the clinical problem: facts and current issues of mucinous cystic neoplasms of the pancreas.

Jeurnink SM, Vleggaar FP, Siersema PD.

Dig Liver Dis. 2008 Nov;40(11):837-46. doi: 10.1016/j.dld.2008.03.018. Epub 2008 May 22. Review.

PMID:
18499541
4.

Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.

Yip-Schneider MT, Wu H, Dumas RP, Hancock BA, Agaram N, Radovich M, Schmidt CM.

J Am Coll Surg. 2014 Apr;218(4):608-17. doi: 10.1016/j.jamcollsurg.2013.12.019. Epub 2013 Dec 24.

PMID:
24491241
5.

Cystic pancreatic neoplasms: observe or operate.

Spinelli KS, Fromwiller TE, Daniel RA, Kiely JM, Nakeeb A, Komorowski RA, Wilson SD, Pitt HA.

Ann Surg. 2004 May;239(5):651-7; discussion 657-9.

6.

Cytologic diagnosis of pancreatic cystic lesions. A prospective study of 28 percutaneous aspirates.

Centeno BA, Warshaw AL, Mayo-Smith W, Southern JF, Lewandrowski K.

Acta Cytol. 1997 Jul-Aug;41(4):972-80.

PMID:
9250287
7.

Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.

Yeh TS, Cheng AJ, Chen TC, Jan YY, Hwang TL, Jeng LB, Chen MF, Wang TC.

J Surg Res. 1999 Dec;87(2):171-7.

PMID:
10600346
8.

Optical coherence tomography to detect epithelial lesions of the main pancreatic duct: an Ex Vivo study.

Testoni PA, Mangiavillano B, Albarello L, Arcidiacono PG, Mariani A, Masci E, Doglioni C.

Am J Gastroenterol. 2005 Dec;100(12):2777-83.

PMID:
16393235
9.

MR imaging of cystic lesions of the pancreas.

Kalb B, Sarmiento JM, Kooby DA, Adsay NV, Martin DR.

Radiographics. 2009 Oct;29(6):1749-65. doi: 10.1148/rg.296095506.

PMID:
19959519
10.

Optical coherence tomography in the assessment of suspicious oral lesions: an immediate ex vivo study.

Hamdoon Z, Jerjes W, Upile T, McKenzie G, Jay A, Hopper C.

Photodiagnosis Photodyn Ther. 2013 Feb;10(1):17-27. doi: 10.1016/j.pdpdt.2012.07.005. Epub 2012 Dec 25.

PMID:
23465368
11.

In vivo optical coherence tomography of the human larynx: normative and benign pathology in 82 patients.

Wong BJ, Jackson RP, Guo S, Ridgway JM, Mahmood U, Su J, Shibuya TY, Crumley RL, Gu M, Armstrong WB, Chen Z.

Laryngoscope. 2005 Nov;115(11):1904-11. Erratum in: Laryngoscope. 2006 Mar;116(3):507.

PMID:
16319597
12.

Validation of full-field optical coherence tomography in distinguishing malignant and benign tissue in resected pancreatic cancer specimens.

van Manen L, Stegehuis PL, FariƱa-Sarasqueta A, de Haan LM, Eggermont J, Bonsing BA, Morreau H, Lelieveldt BPF, van de Velde CJH, Vahrmeijer AL, Dijkstra J, Mieog JSD.

PLoS One. 2017 Apr 17;12(4):e0175862. doi: 10.1371/journal.pone.0175862. eCollection 2017.

13.

Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms.

Rubin D, Warshaw AL, Southern JF, Pins M, Compton CC, Lewandrowski KB.

Surgery. 1994 Jan;115(1):52-5.

PMID:
8284761
14.

Feasibility of optical coherence tomography imaging to characterize renal neoplasms: limitations in resolution and depth of penetration.

Linehan JA, Bracamonte ER, Hariri LP, Sokoloff MH, Rice PS, Barton JK, Nguyen MM.

BJU Int. 2011 Dec;108(11):1820-4. doi: 10.1111/j.1464-410X.2011.10282.x. Epub 2011 May 18.

15.

Mucin secreting cystic lesions of the pancreas: treatment by enucleation.

Madura JA, Yum MN, Lehman GA, Sherman S, Schmidt CM.

Am Surg. 2004 Feb;70(2):106-12; discussion 113. Review.

PMID:
15011911
16.

Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.

Yang JM, Southern JF, Warshaw AL, Lewandrowski KB.

Am J Surg. 1996 Jan;171(1):126-9; discussion 129-30.

PMID:
8554126
17.
18.

Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms.

Haab BB, Porter A, Yue T, Li L, Scheiman J, Anderson MA, Barnes D, Schmidt CM, Feng Z, Simeone DM.

Ann Surg. 2010 May;251(5):937-45. doi: 10.1097/SLA.0b013e3181d7738d.

19.

MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas.

Henry JC, Bassi C, Giovinazzo F, Bloomston M.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S661-6. doi: 10.1245/s10434-013-3138-8. Epub 2013 Jul 25.

PMID:
23884752
20.

Cystic lesions of the pancreas: radiologic-endosonographic correlation.

Kucera JN, Kucera S, Perrin SD, Caracciolo JT, Schmulewitz N, Kedar RP.

Radiographics. 2012 Nov-Dec;32(7):E283-301. doi: 10.1148/rg.327125019.

PMID:
23150863

Supplemental Content

Support Center